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Kcne4 deletion sex- and age-speciﬁcally impairs cardiac
repolarization in mice
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and Geoffrey W. Abbott*,3
*Bioelectricity Laboratory, Department of Pharmacology and Department of Physiology and Biophysics,
School of Medicine, University of California, Irvine, Irvine, California, USA; †Department of
Anesthesiology and Translational Neuroscience Center, West China Hospital, Sichuan University,
Chengdu, People’s Republic of China; ‡Section of Nephrology, Department of Medicine, University of
Chicago, Chicago, Illinois, USA; and §Department of Biochemistry, Brandeis University, Waltham,
Massachusetts, USA
ABSTRACT Myocardial repolarization capacity varies
with sex, age, and pathology; the molecular basis for this
variation is incompletely understood.Here, we show that
the transcript for KCNE4, a voltage-gated potassium
(Kv) channel b subunit associated with human atrial ﬁ-
brillation, was 8-fold more highly expressed in the male
left ventricle compared with females in young adult
C57BL/6 mice (P < 0.05). Similarly, Kv current density
was 25% greater in ventricular myocytes from young
adult males (P < 0.05). Germ-line Kcne4 deletion elimi-
nated the sex-speciﬁcKv current disparity by diminishing
ventricular fast transient outward current (Ito,f) and
slowly activating K+ current (IK,slow1). Kcne4 deletion
also reduced Kv currents in male mouse atrial myocytes,
by >45% (P < 0.001). As we previously found for Kv4.2
(which generates mouse Ito,f), heterologously expressed
KCNE4 functionally regulated Kv1.5 (the Kv a subunit
that generates IKslow1 inmice).Ofnote, inpostmenopausal
female mice, ventricular repolarization was impaired
by Kcne4 deletion, and ventricular Kcne4 expression in-
creased to match that of males. Moreover, castration
diminished male ventricular Kcne4 expression 2.8-fold,
whereas 5a-dihydrotestosterone (DHT) implants in cas-
trated mice increased Kcne4 expression >3-fold (P = 0.01)
to match noncastrated levels. KCNE4 is thereby shown
to be a DHT-regulated determinant of cardiac excitability
and a molecular substrate for sex- and age-dependent
cardiac arrhythmogenesis.—Crump, S. M., Hu, Z., Kant, R.,
Levy, D. I., Goldstein, S. A. N., Abbott, G. W. Kcne4 de-
letion sex- and age-speciﬁcally impairs cardiac repolari-
zation inmice.FASEB J.30, 360–369 (2016).www.fasebj.org
Cardiac myocyte repolarization is a complex process re-
quiring the concerted action of several different types
of potassium channel (1). Voltage-gated potassium (Kv)
channels comprise both pore-forming a subunits and
regulatoryproteins includingb subunits suchas the single-
pass transmembrane KCNE proteins (2) (Fig. 1A).
In human ventricular myocardium, the delayed rec-
tiﬁer currents IKr and IKs are the primary repolarizing
currents. Generated by hERG and KCNQ1 Kv a sub-
units, respectively, these K+ currents repolarize ven-
tricular myocytes after a plateau phase lasting several
hundred milliseconds (1). In adult mouse ventricles,
ventricularmyocyte action potentials aremuch shorter;
IKr is absent, and IKs is, at most, weakly expressed and
detectable only after b-adrenergic stimulation (3). In-
stead, the rapidly activating and inactivating Ito and
the rapidly activating, slowly inactivating K+ current (IK,slow)
dominate adult mouse ventricular repolarization (4).
It is noteworthy that various members of the KCNE
family, of which there are 5 members in mammals, are
expressed in both human and mouse heart. The KCNE
proteins can each form complexes with 1 or more Kv a
subunits, generating heteromeric channel assemblies
oftenwith unique gating or other functional properties
(2). KCNE subunits can also regulate a subunit traf-
ﬁcking and subcellular localization (5). Although hu-
man andmouse hearts exhibit fundamental differences
in the K+ currents that shape their action potentials,
previous studies have demonstrated that the same
KCNE isoforms can be inﬂuential in myocardial repo-
larization of either species—at least partly because of
their functional versatility (6, 7). KCNE gene variants are
linked to human cardiac arrhythmias including Long
QT syndrome, atrial ﬁbrillation (AF), and Brugada syn-
drome; Kcne gene deletion in mice can cause analogous
pathologies (8).
Abbreviations: 4-AP, 4-aminopyridine; AF, atrial ﬁbrillation;
ARE, androgen-responsive element; BSA, bovine serum albumin;
CFP, cyan ﬂuorescent protein; CHO, Chinese hamster ovary;
co-IP, coimmunoprecipitation; DHT, 5a-dihydrotestosterone;
HEPES, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid;
IF, immunoﬂuorescence; IK ,slow, slowly activating K
+ current;
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An important issue in human cardiac arrhythmia is the
variable penetrance of disease between individuals harbor-
ing the same gene variant. One of the more important
sources of variability is the sex of the individual (9). Brugada
syndrome,most commonly linked to loss-of-functionSCN5A
variants, is 8-fold more common in men than women (10).
Reduced repolarization reserve and lower IKr density are
more commonly observed in women than in men and pre-
dispose todrug-inducedcardiacarrhythmia(9).Uncovering
sex-dependent differences in arrhythmia susceptibility and
themolecular mechanisms underlying them is therefore an
early step toward therapeutic strategies tailored toward the
individual (i.e., precision medicine) (11).
KCNE4, which we originally named MinK-related
peptide 3 (6), functionally regulates KCNQ1, Kv1.1,
Kv1.3, Kv4.2, Kv4.3, and the Ca
2+-activated K1 channel,
in heterologous coexpression experiments (12–18). A
Figure 1. Kcne4 deletion sex-speciﬁcally impairs mouse ventricular myocyte K+ currents. A) Cartoon of KCNE4 subunits in a Kva-
KCNE4 channel complex, with a hypothetical 4:2 stoichiometry. B) Strategy for germ-line Kcne4 deletion from mice (Materials and
Methods). C) Genotyping gel of PCR of genomic DNA extracted from tail tip tissue conﬁrming Kcne4 deletion from mice. D) Relative
Kcne4 expression by real-time qPCR quantiﬁcation of sexually mature adult (6 mo old) mouse heart chambers. *P , 0.05 compared
with corresponding female ventricles. All values were normalized to one of the 4- to 6-mo-old male Kcne4+/+ mouse LV Kcne4
expression values. E) Representative whole-cell ventricular septal cardiomyocyte K+ currents from male and female sexually mature
adult (10 mo old) Kcne4+/+ and Kcne42/2mice (voltage protocol inset); n = 9–26 myocytes from 3 to 6 mice per group. F) Mean peak
and steady-state whole-cell ventricular septal cardiomyocyte K+ current densities recorded from cells as in C, isolated from male (M) or
female (F) mice; genotypes are as shown. *P , 0.05 compared with other peak currents at equivalent voltages; n = 9–26 cells per
group, as indicated.
(continued from previous page)
Ito,f, fast transient outward current; Ito,s, slow transient out-
ward current; K v, voltage-gated potassium; qPCR, quantita-
tive PCR; QTc, corrected QT interval; ss, steady state; TEA,
tetraethylammonium
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single nucleotide polymorphism generating an E145D
substitution, positioned in the atypically lengthy cyto-
plasmic C-terminal end of KCNE4, is an independent
risk factor for AF in Han (in 3 separate analyses)
and Uygur Chinese (19–21). KCNE4 inhibits KCNQ1
activity, but E145D-KCNE4 augments KCNQ1 current,
suggesting a potential mechanistic basis for E145D-
associated AF (22). Here, we examined the effects of
targeted Kcne4 gene deletion in mice and discovered
sex-dependent differences in expression and function
that were explained by 5a-dihydrotestosterone (DHT)
regulation of cardiac KCNE4 expression.
MATERIALS AND METHODS
Kcne4─/─ mice
Mice were housed in a pathogen-free facility. The present
study was approved by the Animal Care and Use Committees
at University of California, Irvine and carried out in accor-
dance with the recommendations in theGuide for the Care and
Use of Laboratory Animals (National Institutes of Health,
Bethesda, MD, USA). C57BL/6 Kcne42/2 mice were gener-
ated by replacement of the sole coding exon of Kcne4 with
neo and LacZ genes (Fig. 1B) in 129/Sv embryonic stem cells
for embryonic injection followed by implantation into a C57
breeder, PCR screening of progeny, and conﬁrmed South-
ern blot analysis (performed by Lexicon, The Woodlands,
TX, USA; and Texas A&M Institute for Genomic Medicine,
College Station, TX, USA; data not shown). Kcne4+/2 mice
were then backcrossed for at least 10 generations into the
C57BL/6 strain. Colony genotyping was performed by con-
ventional PCR of genomic DNA isolated from tail tip tissue
(Fig. 1C). The PCR primer sequences were as follows: Kcne4
forward 59-CAACGACAGCAGTGAAGGC-39, Kcne4 reverse
59-GCAGAGCAAAAGCAAAACCC-39, Neo3a 59-GCAGCG-
CATCGCCTTCTATC-39; Kcne4+/+ band, 137 bp, Kcne42/2
band, 229 bp. Castration and DHT pellet implants (7.5 mg
DHT, 90-d release; Innovative Research of America, Sarasota,
FL, USA) were performed by Charles River Laboratories
(Hollister, CA, USA).
Real-time quantitative PCR
Mice were killed by CO2 asphyxiation. Hearts were quickly
harvested, washed, and perfused through the left ventricle
with PBS + heparin and then processed or stored at 280°C
until use. RNA was extracted using 1 ml Trizol (Invitrogen,
Carlsbad, CA, USA)/100 mg tissue and puriﬁed using the
RNeasyMini Kit (Qiagen, Valencia, CA,USA) according to the
manufacturers’ protocol. RNA samples with A260/A280 absor-
bance ratios between 2.00 and 2.20 were used for further
synthesis; 500 ng to 1 mg RNA was used for cDNA synthesis
(Quantitect Reverse Transcriptase; Qiagen) and stored
at220°C until use. Primer pairs for target genes Kcne4 (NCBI
Gene ID 57814) and GAPDH (NCBI Gene ID: 14433) pro-
duced an amplicon of 137 and 123 bp, respectively. Primer
sequences were obtained from MGH-ParaBioSys:NHLBI
Program for Genomic Applications, Massachusetts General
Hospital, and Harvard Medical School (Boston, MA, USA)
(http://pga.mgh.harvard.edu). The sequences of primers
(0.05 mm scale, HPLC puriﬁed; Sigma-Aldrich, St. Louis, MO,
USA) were as follows: Kcne4, forward 59-CTTTGCTCGATG-
GAAGGGGAC-39, reverse 59-GCTGTCGTTGAGAGGCGTC-39;
Gapdh, forward 59-AGGTCGGTGTGAACGGATTTG-39, reverse
59-TGTAGACCATGTAGTTGAGGTCA-39. Real-time quantitative
PCR (qPCR) analysis was performed using the CFX Connect Sys-
tem, iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules,
CA,USA)and96-well clearplates.Thermocyclingparameterswere
set according to the manufacturer’s protocol for iTaq. Samples
were run in triplicate as a quality control measure, and triplicates
with an SD of 0.600 or higher were repeated. Melting curves were
assessed for veriﬁcation of a single product. Final analysis measur-
ing statistical signiﬁcance was calculated measuring ΔΔCq values
normalized to the 6-mo-old male Kcne4+/+ left ventricle data.
Antibodies
Chicken and rabbit antibodies were generated to human KCNE4
residues67–138 forWesternblot/coimmunoprecipitation(co-IP)
and residues 136–150 for immunoﬂuorescence (IF), respectively,
as described previously (18). Commercial voltage-gated K+ chan-
nel antibodies raised against rabbit anti-Kv1.5 (Alomone Labora-
tories, Jerusalem, Israel) were used for Western blots and IF as
described previously (7, 23).
Isolation of adult mouse cardiomyocytes
Single cardiomyocytes were isolated from sexually mature adult
(10 mo old) mice that were heparinized using (250 IU, i.p., to
minimize blood clotting) for 10minbeforeCO2 gas and cervical
dislocation.Thechestwasopened toexpose theheart and lungs.
Hearts were quickly excised, and cannulationof ascending aorta
was perfused on a 37°C warmed Langendorff apparatus (Easy
CellExtractionSystemType 803;HugoSacksElektronik,March-
Hugstetten, Germany) constantly gassed with 95% O2–5%
CO2. The hearts were perfused at 3ml/min with calcium-free
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)
buffer containing the following (in mM): 137 NaCl, 5.4 KCl, 1.2
MgSO4, 15 NaH2PO4, 20 glucose, 10 HEPES, and 2 L-glutamine
(pH7.4, bufferA) for 5min, followedby10–14minof 0.36mg/ml
type II collagenase (Worthington, Lakewood, NJ, USA) and
10 mM CaCl2 (buffer B) or until the hearts were swollen and
pale in color. The hearts were transferred to a 10 cm dish
containing buffer A supplemented with 5mg/ml bovine serum
albumin (BSA) and 150mMCaCl2 (buffer C) andmechanically
dissociated using forceps until large pieces were dispersed
into the cells suspension. Undigested tissue debris were ﬁltered
througha 200mMnylonmesh into a Falcon tube, and 2 volumes
of buffer A supplemented with 5 mg/ml BSA and 1 mM CaCl2
solution (buffer D) were added and allowed to settle for 5 min.
Cells were rinsed and pelleted 2 times at 300 rpm for 3min and
resuspended in buffer D. Cells were resuspended to desired
cell concentration using buffer D for electrophysiology or
seeded on laminin (Corning, Tewksbury, MA, USA)-coated
glass coverslips (15 mg/ml) for IF assay. Only rod-shaped
cardiomyocytes with clear striations were used for recording.
Cellular electrophysiology
Whole-cell patch-clamp recordings from dispersed adult car-
diomyocytes or transfected Chinese hamster ovary (CHO) cells
were performed at room temperature using an IX50 inverted
microscope equipped with an FHD chamber from IonOptix
(Olympus, Center Valley, PA, USA), a Multiclamp 700A Am-
pliﬁer, a Digidata 1300 Analog/Digital converter, and PC with
pClamp9 software (Molecular Devices, Sunnyvale, CA, USA).
For cardiomyocytes, the bath solution contained the following
(in mM): 117 NaCl, 4 KCl, 1.7 MgCl2, 10 HEPES, 1 KH2PO4,
4 NaHCO3, 3 CoCl2, and 10 D-glucose (pH 7.4 with NaOH).
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Pipettes were of 2.1–3.2 MV resistance when ﬁlled with in-
tracellular solution containing the following (in mM): 130 KCl,
2 MgCl2, 20 HEPES, 11 EGTA, 5 Na2ATP, 0.4 Na2GTP, and
5 Na2CP (pH 7.4 with KOH). Outward K
+ currents were evoked
during 4.5 second voltage steps to test potentials between –60
and +60 mV in 20 mV increments from a holding potential of
–70 mV after a 100 ms prepulse to –40 mV. Leak currents were
always ,100 pA and were not corrected. Data were analyzed
using pClamp9.1 software (Molecular Devices, Sunnyvale, CA,
USA), and statistical analysis (ANOVA) was performed using
Origin 6.1 (Microcal, Northampton, MA, USA) software. The
decay phase of IK was ﬁtted to the sum of 3 exponentials to
quantify the t of decay and current amplitude for IK,slow, fast
transient outward current (Ito,f), and slow transient outward
current (Ito,s) as before (7).
For inhibition of Kv1.5 and Kv2.1, respectively, 50 mM
4-aminopyridine (4-AP; ICNBiomedicals, Irvine, CA, USA) and
25 mM tetraethylammonium (TEA; Sigma-Aldrich) bath solu-
tions were applied to the recording bath to achieve at least
43 bulk ﬂow bath displacement after baseline recordings and
allowed to equilibrate for 2–3 min before drug recordings.
For whole-cell patch clamp of CHO cells, bath solution
contained the following (in mM): 135 NaCl, 5 KCl, 1.2 MgCl2,
5 HEPES, 2.5 CaCl2, and 10 D-glucose (pH 7.4). Pipettes were
2.1–3.5 MV resistance when ﬁlled with intracellular solution
containing the following (in mM): 10 NaCl, 117 KCl, 2 MgCl2,
11 HEPES, 11 EGTA, and 1 CaCl2 (pH 7.2). K
+ currents were
evoked during a 1 second voltage step in 10 mV increments
between280 and +60mV from aholding potential of275mV.
Green ﬂuorescent protein-positive cells were selected for re-
cording 24 h after transfection.
For all current and current density comparisons, currents be-
tween0 and50or 60mVwere comparedbetweengenotypes, with
ANOVA followed by Bonferroni correction for multiple com-
parisons to determine P values.
Cell culture and transfection
CHO cells were cultured at 37°C and 5% CO2 in F12K medium
(ATCC, Manassas, VA, USA) containing L-glutamine and so-
dium bicarbonate supplemented with 10% fetal bovine serum
(Invitrogen) plus 1% penicillin and streptomycin. CHO cells
were cultured in 10 cm tissue culture plates to 80% conﬂuence.
Next,CHOcells werewashedoncewithPBS (Ca2+ andMg2+ free;
Invitrogen) and then incubated with Detachin (Genlantis, San
Diego, CA, USA) for 3 min. Fetal bovine serum–supplemented
F12Kmediumwas added, and cells were centrifuged for 2min at
1000 rpm. For transfection, 23 105 cells were seeded in 35 mm
tissue culture dishes 2 h before transfection. CHO medium was
replaced with prewarmed Opti-MEM reduced serum medium
(Invitrogen) and transiently transfected using a 2:1 ratio of
Lipofectamine 2000 (Invitrogen) to cDNA. Speciﬁcally for elec-
trophysiology, cells were transfected with 0.02 mg human-Kv1.5
cDNA, 0.02 mg mouse-Kcne4 cDNA, 2.47 mg pBluescript (cells
transfectedwithoutKcne4used2.49mgpBluescript), and0.147mg
enhanced green ﬂuorescent protein added (for identiﬁcation of
transfected cells) to 250 ml of Opti-MEM, followed by dropwise
addition of Lipofectamine 2000 and incubated at room temper-
ature for20min.Cellmediumwas replacedwith freshprewarmed
10% fetal bovine serum–supplemented F12K medium after 3 h
of transfection. Whole-cell patch-clamp or IF experiments were
conducted 24 h after transfection.
Immunoﬂuorescence
CHO cells (4 3 105 cells per 10 cm dish) were transfected as
described above and then rinsed twice in ice-cold PBS before
ﬁxation in ice-cold 4% paraformaldehyde for 10 min. All treat-
ments for the rest of the procedure were at room temperature.
Following ﬁxation in formaldehyde, cells were permeated with
PBS containing 0.25% Triton X-100 in 1% BSA for 10 min and
then rinsed 3 times for 5 min with PBS. The cells were blocked
with 1% BSA + 10% normal goat serum in PBS/0.25% Triton
X-100 for 30min.Blockingbufferwas changed toprimaryantibody
(1:200) and incubated for 3 h followed by 33 5 min PBS rinses.
Cells were then incubated with secondary Fluor-antibodies
(1:600) in 1% BSA/10% normal goat serum/PBS/0.25% Triton
X-100 for 1 h. Cells were washed 33 5minwith PBS, and then the
coverslips were mounted with DAPI-labeled mounting medium
and visualized after drying using an Olympus BX51 microscope
andCellSens software (Olympus,Waltham,MA,USA). Secondary
antibodies used were donkey anti-chicken 488 and goat anti–
rabbit-555 (Invitrogen). Effects of KCNE4 on Kv1.5 surface ex-
pression in live CHO cells were quantiﬁed using Nikon NIS
Elements v4.10 software via a primary antibody raised against an
extracellular epitope of Kv1.5 (APC-150; Alomone Laboratories);
total cell Kv1.5 expression was quantiﬁed via a C-terminal cyan
ﬂuorescent protein (CFP) tag while maintaining the same time
capture exposure for all images. In brief, a circular region of
interestwasoverlaidandadjusted to theexact sizeof theCFP-Kv1.5
signal boundary to measure ﬂuorescence. Next, the same
circular region of interest pixel area and coordinates were used
to measure the anti-Kv1.5 cell ﬂuorescence in the same cell.
Anti-Kv1.5 ﬂuorescence was normalized to total Kv1.5-CFP
ﬂuorescence.
Western blot and co-IP
CHO cells were transiently transfected overnight with a 3:1 ratio
of LT1 (Mirus, Madison,WI, USA) to cDNA in an 80% conﬂuent
10 cm plate containing 2 mg human Kv1.5 + 2 mg mouse Kcne4 +
11 mg pBluescript. CHO cells were lysed 24 h after transfection
after they were scraped, pelleted at 1000 rpm for 2min, and then
washed once in PBS. The cell pellet was lysed with 450 ml buffer
containing 150 mM NaCl, 50 mM Tris, 1% Nonidet P-40, and
0.1% SDS (Sigma-Aldrich) with protease inhibitor (Thermo
Fisher Scientiﬁc, Waltham, MA, USA), pH to 7.4, for 1 h at 4°C
whilerotating.Lysateswerepelleted for10minat10,000 rpm,and
supernatant was collected for BCA protein quantiﬁcation
(Thermo Fisher Scientiﬁc) after preclearing with 40 ml of Pierce
agarose A beads (Thermo Fisher Scientiﬁc). For Western blot
analysis, 15 mg lysate per lane was fractionated by SDS-PAGE,
transferred onto PVDFmembranes, and probed with anti-Kcne4
or anti-Kv1.5 antibody, followed by horseradish peroxidase–
conjugated goat anti-rabbit IgG secondary antibody (Bio-Rad)
or goat anti-chicken IgY secondary antibody (Aves Laborato-
ries, Tigard, OR, USA) for visualization with ﬂuorography
(ECL-plus; Amersham Biosciences/GE Healthcare Life Sci-
ences, Marlborough, MA, USA). For co-IPs, 350 mg lysates was
incubated overnight with primary antibody at 4°C, and then
40 ml of Pierce agarose A beads was added for 1 h. Beads
were washed 33 5 min with lysis buffer and eluted with Tris
(2-carboxyethyl)phosphine hydrochloride and NuPage LDS
loading buffer (Novex Life Technologies, Carlsbad, CA, USA)
at 95°C for 5 min. Elutions (20 ml/lane) were fractionated by
SDS-PAGE as above for Western blotting. Blots were visualized
using SynGene G:Box Chemi XR5, running Genesys software,
v1.4.3 (Syngene, Frederick, MD, USA).
Electrocardiography and hemodynamic analyses
Mice in 3 age groups (4, 12, and 17 mo old) were anesthetized
with 2% isoﬂurane, and surgical anesthesia was veriﬁed by a lack
of response to toe pinch. The standard limb lead II conﬁguration
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electrocardiographic systemwas inserted subcutaneously to limbs
by needle electrodes, and electrocardiograms were recorded
throughout the study. QT, RR, PR, and QRS intervals and
heart rate were analyzed ofﬂine after acquisition. Corrected
QT interval (QTc) was calculated based on Mitchell’s formula
speciﬁcally for mice (24): QTc = QT/(RR/100)
1/2. For he-
modynamic analysis, the right carotid artery was exposed
through a cervical midline incision, and the left ventricle was
catheterized via the right carotid artery using a 1.0 F Millar
Micro-Tip catheter transducer (model SPR-1000) connected
to a pressure transducer (Millar Instruments, Houston, TX,
USA). Baseline blood pressures were recorded before advanc-
ing the catheter into the left ventricle. The real-time data were
collected by Powerlab/8sp system (ADInstruments, Colorado
Springs, CO,USA). LabChart 7.2.1 software (ADInstruments) was
used for electrocardiographic and hemodynamic data acquisition
and analysis.
RESULTS
Kcne4 transcript expression is enriched in ventricles
of male sexually mature mice
We ﬁrst quantiﬁed mouse cardiac Kcne4 expression by
real-time qPCRusingKcne42/2 tissue as a negative control
and to further conﬁrmgenotype. In sexuallymaturemice,
Kcne4 expression was highest in the left ventricle of male
mice, next highest in the male mouse right ventricle, and
then the male atria, and was comparatively low in all 4
female heart chambers (Fig. 1D).
Kcne4 deletion sex-speciﬁcally impairs ventricular and
atrial myocyte repolarization in mice
We next measured Kv currents using whole-cell patch
clamp of ventricular myocytes isolated from sexually ma-
ture Kcne4+/+ and Kcne42/2 mice. Mean current density
(peak and sustained current) was unaffected by Kcne4 de-
letion in female ventricular myocytes isolated from the
septum (Fig. 1E, F) and also those from the apex (Sup-
plemental Fig. S1). This was consistent with the relatively
low expression of Kcne4 in the female mouse heart. In
contrast,Kcne4deletion reducedpeakKv current density in
male ventricular septal myocytes to match that of females
but did not alter sustained currents (Fig. 1E, F).
The 3 major components of adult mouse ventricular
myocyte Kv currents (Ito,f, Ito,s, and IK,slow) can be isolated by
ﬁtting current decay with 3 exponential functions, dis-
tinguishing their 3 different inactivation rates, and permit-
ting quantiﬁcation of the amplitude of each component (7,
25). The inactivation kinetics of the Kcne4-dependent
current in males were consistent with it comprising both
the rapidly inactivating Ito,f (generated by Kv4 subunits in
musine and human ventricles) and the more slowly inac-
tivating IK,slow (generated by Kv1.5 and Kv2.1 a subunits in
adult mouse ventricles), but not the intermediate-
inactivating Ito,s (generated by Kv1.4 in adult mouse ven-
tricles) (Fig. 2A, B). We previously demonstrated that
KCNE4 augments Kv4.2 activity (17), consistent with the
reduction in Ito,f observed here on Kcne4 deletion.
Figure 2. Kcne4 deletion impairs male mouse
ventricular myocyte Ito,f and IK,slow1. A, B) Mean
amplitude (A) and decay time constant, t (B), of
current components after curve-ﬁtting whole-cell
ventricular septal cardiomyocyte K+ current traces
from male sexually mature adult Kcne4+/+ and
Kcne42/2 mice as in Fig. 1E, F; n = 9–26 myocytes
from 3 to 6 mice per group. C) Exemplar
digitally subtracted 50 mM 4-AP–sensitive K+
current (IK,slow1) traces recorded from cells as in
Fig. 1E, F; genotypes are as shown; n = 18–19.
D) Mean digitally subtracted 50 mM 4-AP–sensitive
K+ current (IK,slow1) densities quantiﬁed from
traces as in C; genotypes are as shown; n = 18–19.
*P , 0.01 comparing current density between
genotypes. E) Exemplar digitally subtracted
25 mM TEA-sensitive K+ current (IK,slow2) traces
recorded from cells as in Fig. 1E, F; genotypes
are as shown; n = 7–9. F) Mean digitally
subtracted 25 mM TEA-sensitive K+ current
(IK,slow2) densities quantiﬁed from traces as in
E; genotypes are as shown; n = 7–9.
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The;50% loss of amplitude in IK,slow suggested a role
for KCNE4 with Kv1.5 and/or Kv2.1 that had not been
previously recognized. Indeed, pharmacologic isolation
of the IK,slow component of the Kcne4-dependent cur-
rent revealed its sensitivity to 50mM4-AP (Fig. 2C, D) but
not 25 mM TEA (Fig. 2E, F). This proﬁle was consistent
with the pharmacologic properties of IK,slow1, generated
by Kv1.5 (7).
Kcne4 deletion also reduced Kv current density in adult
malemouse atrial myocytes, by.45% at +40mV (P, 0.001;
Fig. 3A, B). Curve ﬁtting with 2 exponentials to isolate
the rapid- and the slow-inactivating current compo-
nents, as previously described for adult mouse atrial
myocytes (26), revealed that the primary current com-
ponent lost byKcne4 deletion was Ito,f (.50% reduction
at +40 mV; P = 0.03; Fig. 3C, D).
KCNE4 colocalizes with and augments activity of Kv1.5
in CHO cells
To validate the notion that KCNE4 directly regulates Kv1.5
channels, we studied the subunits heterologously expressed
in CHO cells. KCNE4 more than doubled the density of
current generated by Kv1.5 (Fig. 4A, B). KCNE4 moderately
increased the slope and left-shifted the voltage dependence
of activationofKv1.5 (Fig. 4C).KCNE4didnotalter activation
kinetics but moderately increased the extent of inactivation
over a 1 second pulse to +40 mV of Kv1.5 (Fig. 4D, E).
KCNE4 colocalized in the plasma membrane of CHO
cells with coexpressed Kv1.5 (Fig. 5A), and Kv1.5-KCNE4
complexes were detectable by co-IP (Fig. 5B). To quantify
effects of KCNE4 on Kv1.5 surface expression, CFP-tagged
Kv1.5 (Kv1.5-CFP) was expressed alone or with KCNE4 and
CFP ﬂuorescence compared with ﬂuorescence from de-
tection of antibody raised to an epitope on the surface of
Kv1.5, using microscopy of live CHO cells. Kv1.5-CFP was
expressed in puncta at the cell surface, and KCNE4 in-
creased the number of puncta (Fig. 5C). Quantiﬁcation of
total and surface ﬂuorescence intensities revealed that
KCNE4didnot alter totalKv1.5-CFPexpressionbutdoubled
Kv1.5-CFP surface expression, whether or not this value was
normalized to total Kv1.5-CFP expression (Fig. 5D).
Ventricular KCNE4 expression is regulated by DHT
Electrocardiographic analyses showed that, in 4-mo-old
male mice, QTc, a measure of the time for ventricular re-
polarization, was unaltered by Kcne4 deletion. In contrast,
Figure 3. Kcne4 deletion impairs male mouse
atrial myocyte Ito,f. A) Representative whole-cell
atrial cardiomyocyte K+ currents from sexually
mature adult male Kcne4+/+ and Kcne42/2 mice
(voltage protocol inset); n = 20 myocytes from 3 to
4 mice per group. B) Mean peak whole-cell atrial
cardiomyocyte K+ current densities recorded from
cells as in A; n = 20, *P , 0.001. C) Averaged K+
current traces elicited by a +40 mV voltage pulse
from atrial myocytes isolated from sexually mature
adult male Kcne4+/+ and Kcne42/2mice (mean of
20 traces per genotype). D) Mean data resulting
from curve ﬁtting of +40 mV traces from record-
ings as in A; n = 14–19.
Figure 4. KCNE4 doubles Kv1.5 current density in CHO cells.
A) Representative whole-cell K+ current traces recorded from
CHO cells 48 h after transfection of Kv1.5 alone or with KCNE4
(voltage protocol inset); n = 20–21. B) Mean peak current
density for cells as in A; n = 20–21, *P , 0.0001. C–E) Mean
voltage dependence of activation (C), time to peak activation
(D), and percent inactivation (E) for currents as in A and B;
n values as in A and B.
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Kcne4 deletion increased QTc by 24% at 12 mo of age and
by 55%at 17moof age inmalemice (Fig. 6A). This pattern
was not entirely unexpected: we observed similar age-
dependentKcne-dependent QTc prolongation in both the
Kcne22/2 and Kcne32/2 mouse lines (27, 28), suggesting
that Kcne2, 3, or 4 deletion requires additional aging-
related erosion of the repolarization reserve tomanifest on
the body surface electrocardiogram.
We also observed aging-dependent QTc prolongation
in female Kcne42/2 mice, except that it occurred with
a later onset than in males. Thus, QTc of female mice was
unalteredbyKcne4deletionat 4 and12mobut increasedby
47% at 17 mo (Fig. 6B), by which age female mice are
postmenopausal (29). ThatKcne4deletionhad an effect on
postmenopausal female QTc was surprising, given the rel-
atively low cardiac expression of KCNE4 in young adult
female mice (Fig. 1B). Other electrocardiographic param-
eters were not changed in either sex (Supplemental Fig.
S2). Similarly, hemodynamic parameters were largely un-
affected by Kcne4 deletion (Supplemental Fig. S3). Mean
minimum change in pressure/time (Min dP/dt) was
high in female Kcne42/2 mice compared with Kcne4+/+
mice (n = 7–8; P = 0.028), but the possible implications
of this will require future investigation.
Given the unexpected importance of the Kcne4 subunit
in ventricular repolarization of postmenopausal female
mice, we quantiﬁed their Kcne4 expression and found
that ventricular Kcne4 expression was.10-fold higher in
Figure 5. KCNE4 forms complexes with, and
doubles surface expression of, Kv1.5 in CHO
cells. A) Fluorescence micrographs showing
plasma membrane colocalization of KCNE4
and Kv1.5, taken 48 h after transfection of CHO
cells. Scale bar, 2.5 mm. B) Left) Coimmuno-
precipitation (IP) of Kv1.5 and KCNE4 from
lysates isolated 48 h after CHO cell transfection.
Proteins were immunoprecipitated with anti-
KCNE4 antibody and immunoblotted (IB) using
anti-Kv1.5 antibody. Arrow, Kv1.5 monomer.
Lysate, lanes loaded with nonimmunoprecipi-
tated lysate for control. cDNAs transfected are
indicated by + and their absence by 2. Right)
Positive control for KCNE4 IP and IB, both using
KCNE4 antibody. Arrow, KCNE4 monomer;
other symbols as in upper blot. C) Fluorescence
micrographs of live CHO cells expressing CFP-
tagged Kv1.5 alone or with KCNE4. Fluorescence
signal detected was either CFP (left) to quantify
total Kv1.5-CFP expression or via antibody raised
to an external epitope on Kv1.5 (right) to quantify
Kv1.5-CFP surface expression, in the same cell.
Scale bar, 2.5 mm. D) Quantiﬁcation of mean
effects of KCNE4 on total (left), surface (center),
and surface/total (right) Kv1.5 expression;
n = 22–23 cells per group.
Figure 6. Effects of Kcne4 deletion on ventricular
repolarization are age and sex dependent. A)
Left) Representative body surface electrocardio-
grams measured from 4- (n = 11) and 17-mo-old
(n = 8–10) male Kcne4+/+ and Kcne42/2 mice as
indicated. Right) Mean QTc values quantiﬁed
from electrocardiograms as in left and from
12-mo-old male mice (n = 5–8). B) Left) Represen-
tative body surface electrocardiograms measured
from 4- (n = 9–10) and 17-mo-old (n = 10–12)
female Kcne4+/+ and Kcne42/2 mice as indicated.
Right) Mean QTc values quantiﬁed from electro-
cardiograms as in left and from 12-mo-old female
mice (n = 3).
366 Vol. 30 January 2016 CRUMP ET AL.The FASEB Journal x www.fasebj.org
 pp. 360-369.
postmenopausal female mice compared with young
sexuallymature (4–6mo old) adult femalemice and was
equivalent to that of young and old adult male mice
(Fig. 7A).
Interestingly, in young adult mice, DHT is very high in
males compared with females (a ratio of.50:1), but DHT
levels rise .4-fold after menopause in female mice (29),
qualitatively matching the pattern we observed for the
Kcne4 transcript. To test the hypothesis that DHT regulates
ventricular Kcne4 expression, we quantiﬁed the latter in
young adult male mice that had been castrated at 2 mo of
age and those that were castrated and simultaneously
implanted with DHT pellets. At 128 d after pellet im-
plantation, left ventricularKcne4 expressionwas.3-fold
higher than that of castrated, nonpellet-implantedmice
(P = 0.01) and similar to that of noncastrated male mice
(Fig. 7A, B). Kcne4 expression 45 d after pellet implan-
tation was intermediate between that of castrated,
nonpellet-implanted and castrated mice 128 d after
DHT pellet implant (Fig. 7B). Consistent with the DHT-
dependent expression of Kcne4 and the observation that
Kcne4 deletion prolongs the QT interval by diminishing
ventricular Kv currents generated by channels regulated
by Kcne4, DHT pellet implantation shortened the QTc
interval in castrated mice (Fig. 7C, D).
DISCUSSION
Our ﬁndings reveal that DHT positively regulates Kcne4
expression in mouse ventricles and that this contributes to
higher Kv current density in young adult male mice com-
pared with their age-matched female counterparts. Post-
menopausal femalemice exhibit an increase in ventricular
Kcne4 expression concomitant with the increased DHT
known to occur on this transition (29). Interestingly, in
a previous study, ventricular myocyte IK,slow density was
found to be higher in male mice than in females, with the
difference linked to DHT regulation of Kv1.5 (30). In that
study, as we recapitulated here (Fig. 7C, D), DHT short-
ened the QTc in castrated mice. Our ﬁndings suggest that
control of QTc by DHT arises from its positive regulation
not just of Kv1.5 but also of KCNE4. Also in the prior study
(30), it was found that C57BL/6 male mice have relatively
low DHT compared with another strain, CD-1, and that
males of the latter strain also exhibit higher 4-AP–sensitive
current density than do C57BL/6 male mice. It is possible
that a backcross of our Kcne4─/─ mice into the CD-1 back-
ground would yield even larger differences in Kcne4 ex-
pression between sexes than seen here.
Our data are the ﬁrst to demonstrate male androgen
regulation of a K+ channel regulatory subunit, although
estrogen (andnotDHT)was previously shown topositively
regulate Kcne2 expression in themurine heart (31). It was
suggested that such regulation provides a mechanism to
counteract other factors causing QT prolongation by re-
ducing the repolarization reserve near the end of ges-
tation, with the surge in estrogen during this period
upregulating Kcne2, which could augment Ito,f and IK,slow1,
based on our previous ﬁndings (7). Similarly, DHT up-
regulation of Kcne4 expression might provide a mecha-
nism for augmenting Ito,f and IK,slow1 in postmenopausal
female mice to counteract the QT-prolonging effects of
aging that we have now observed in 3 separate Kcne─/─
mouse colonies (27, 28).
It therefore appears that Kcne2 and Kcne4 serve, in
some ways, similar roles in mouse ventricles, each aug-
menting both Ito and IKslow,1, Kcne2 being relatively more
Figure 7. DHT regulates ventricular Kcne4 expres-
sion and ventricular repolarization. A) Real-time
qPCR quantiﬁcation of Kcne4 expression in 4- and
17-mo-old mouse heart left ventricles. Kcne42/2
tissue (open columns) was used as a negative
control. Kcne4 expression levels for young adult
male and female left ventricles are repeated
from Fig. 1D for comparison. All values were
normalized to one of the 4- to 6-mo-old male
Kcne4+/+ mouse Kcne4 expression values. B)
Real-time qPCR quantiﬁcation of Kcne4 ex-
pression in left ventricles from castrated mice
(light gray, n = 9), and castrated/DHT pellet-
implanted young adult male mice 45 (medium
gray, n = 5) and 128 d (dark gray, n = 4) after
implant, each quantiﬁed in triplicate. Kcne4
expression in nonpellet-implanted vs. 128 d
after pellet implant, P = 0.01; all other compar-
isons, P . 0.05, by Tukey honest signiﬁcant
difference, Scheffe´ multiple comparison, or
Bonferroni and Holm multiple comparison. All
values were normalized to one of the 4- to 6-
mo-old male Kcne4+/+ mouse Kcne4 expression
values from A. C) Representative body surface
electrocardiograms measured from 6-mo-old
castrated (n = 5) and castrated, DHT pellet-
implanted (128 d) male Kcne4+/+ mice as
indicated. D) Mean QTc values quantiﬁed
from electrocardiograms as in C (n = 5).
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prominent in the female heart because of positive regula-
tion by estrogen and Kcne4 more important in males be-
cause of positive regulation by DHT. Both Kcne2 and
Kcne4 are expressed in multiple tissues outside the heart
(32), yet hormonal regulation of these subunits in other
tissues has not been studied. To fully understand the
ramiﬁcations of this mode of regulation, a more compre-
hensive analysis is warranted. In addition, we do not yet
know the mechanism by which DHT regulates Kcne4 ex-
pression. Typically, DHTbinds to androgen receptors, and
the complex translocates to the nucleus, where it binds to
androgen-responsive elements (AREs) on speciﬁc genes.
We did not ﬁnd a canonical ARE within the mouse Kcne4
gene sequence, suggesting either Kcne4 harbors a non-
canonical ARE or DHT increases Kcne4 expression by ac-
tivatinganotherprotein (e.g., another transcription factor).
DHT can also act nongenomically (e.g., its binding to an-
drogen receptors can rapidly activate mitogen-activated
protein kinases), resulting in downstream activation of
transcription factors (33)—another avenue to explore in
future directions.
It is possible that Kcne4 is upregulated by DHT to
mirror DHT up-regulation of Kv1.5 similar to the co-
ordinated expression of Kv4 and KChIP subunits in mice
(34), presumably to avoid the deleterious effects of ex-
pression of Kv1.5 without the modiﬁcations produced by
Kcne4 on channel function and trafﬁcking that might
result from an expression level mismatch. The same
might apply to Kv4.2 and/or Kv4.3, the subunits gener-
ating Ito,f in mouse ventricles. Kv4.3 was previously found
to be upregulated by testosterone in female canine ven-
tricles andmore highly expressed in normalmale than in
normal female ventricles (35).
Turning to the atria, we found that Kcne4 deletion pri-
marily affected Ito,f, reducing current density bymore than
half, although we did not detect spontaneous atrial
arrhythmias inKcne4─/─mice. The 36% reduction in IK,slow
density did not reach the P , 0.05 signiﬁcance level, but
was comparable to the effect we observed for ventricular
IK,slow of male Kcne4
─/─ mice. In human heart, KCNE4
expression is reported to be 2-fold higher in the atria over
the ventricles (36); this may explain the link between
KCNE4 and AF (19–21), whereas ventricular arrhythmias
have not been reported to date. Interestingly, unlike in the
adult murine heart, Kv1.5 in the human heart is enriched
in the atria compared with the ventricles (where it is difﬁ-
cult to detect) (37). Prior studies of the human KCNE4
G/T polymorphism at position 1057 found that the T allele
(generating the KCNE4 145D vs. 145E for the G allele) is
associated with increased incidence of AF (19–21). In vitro
studies showed that KCNE4-145D augmented KCNQ1
current, whereas 145E inhibited it, a plausiblemechanism
for AF (22). In light of our ﬁndings, it will be of interest to
compare the effects of the 2 human KCNE4 variants on
Kv1.5 and Kv4.2/3 channel properties to determine
whether these potentially contribute to, or counteract,
effects on KCNQ1.
Finally, further studies are required to determine
whether KCNE4 and KCNE2 are also regulated by hor-
mones in human heart. AF is muchmore common in the
elderly than in the young and afﬂicts millions within the
aging population in the United States alone. As testos-
terone levels diminish later in life in men, it will be
important to determine how the predicted reduction in
cardiac KCNE4 associated with this might affect suscep-
tibility to AF and to consider the potential safety and
efﬁcacy of correcting this with hormonal therapy. In
a recent analysis of the Framingham Heart Study, tes-
tosterone deﬁciency in men of 80 yr of age and older was
found to be strongly associated with AF risk, whereas the
mechanistic basis remains incompletely understood
(38). The results of mouse studies cannot be directly
extrapolated to the human heart because of major dif-
ferences in, for example, heart rate, chamber size, andKv
channel subunit expression. However, the more we un-
derstand about these differences, themore effectively we
can use studies of the genetically highly tractable mouse
to generate testablehypotheses relating to crucial aspects
of human cardiac physiology and the pathogenesis of
debilitating or lethal cardiac arrhythmias.
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